Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Keeps Cessation As ‘Gold Standard’ For NRT Indication As Critics Question Its Worth
Oct 23 2024
•
By
Malcolm Spicer
(Shutterstock)
More from Regulation
More from Ingredients & Safety